V011-8707 Screening compound: N-[4-(4-ethylpiperazin-1-yl)-3-[(1-phenylethyl)sulfamoyl]phenyl]-2H-1,3-benzodioxole-5-carboxamide

V011-8707 Screening compound: N-[4-(4-ethylpiperazin-1-yl)-3-[(1-phenylethyl)sulfamoyl]phenyl]-2H-1,3-benzodioxole-5-carboxamide
V011-8707 Screening compound: N-[4-(4-ethylpiperazin-1-yl)-3-[(1-phenylethyl)sulfamoyl]phenyl]-2H-1,3-benzodioxole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-8707
N-[4-(4-ethylpiperazin-1-yl)-3-[(1-phenylethyl)sulfamoyl]phenyl]-2H-1,3-benzodioxole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-8707

Molecular Formula

C28H32N4O5S (C28 H32 N4 O5 S)

Compound Name

N-[4-(4-ethylpiperazin-1-yl)-3-[(1-phenylethyl)sulfamoyl]phenyl]-2H-1,3-benzodioxole-5-carboxamide

IUPAC name

N-[4-(4-ethylpiperazin-1-yl)-3-[(1-phenylethyl)sulfamoyl]phenyl]-2H-13-benzodioxole-5-carboxamide

SMILES

CCN(CC1)CCN1c(ccc(NC(c(cc1)cc2c1OCO2)=O)c1)c1S(NC(C)c1ccccc1)(=O)=O

InChI

InChI=1S/C28H32N4O5S/c1-3-31-13-15-32(16-14-31)24-11-10-23(29-28(33)22-9-12-25-26(17-22)37-19-36-25)18-27(24)38(34,35)30-20(2)21-7-5-4-6-8-21/h4-12,17-18,20,30H,3,13-16,19H2,1-2H3,(H,29,33)/t20-/m0/s1

InChI Key

MJBOPFXDSXBYLN-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD19972505

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

536.65

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.253

Distribution Coefficient, logD

3.792

Water Solubility, LogSw

-4.06

Polar Surface Area

88.268

Acid Dissociation Constant (pKa)

9.89

Base Dissociation Constant (pKb)

7.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.14

V011-8707 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V011-8707 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-8707?
Check Price and Availability of V011-8707, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-8707 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-8707
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-8707
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-8707 available by request